Right of First Refusal on SPV Secondaries

A ROFR secondary SPV deal is not done when the buyer and seller agree on price. A right of first refusal (ROFR) — and often a right of first offer, co-sale, or company consent — can force the seller to offer the same economics to the company or existing holders before your SPV can close. Underwrite the transfer restrictions before you form the vehicle.

This is general information, not legal, tax, or investment advice, and not an offer to buy or sell any security. Private-company securities are illiquid. Company consent and transfer restrictions can block a transfer after a match. If a broker-dealer channel is involved, Allocations Securities, LLC dba AllocationsX (FINRA/SIPC, CRD 317750) is the broker-dealer for Allocations’ secondary market — a separate capacity from SPV administration.

What a ROFR secondary SPV actually hits

A secondary SPV pools capital to buy existing shares from a holder, not a new issuance from the company. The SPV becomes (or hopes to become) the shareholder of record. That transfer sits under the company’s charter, bylaws, investors’ rights agreement, stock purchase agreement, and any stockholder agreement that bind the seller’s shares.

ROFR means a named party — often the company, sometimes major investors — gets a contractual window to buy the offered shares on the same material terms as the third-party buyer. ROFO (right of first offer) usually requires the seller to solicit the preferred party first, before shopping the block. Consent is a separate gate: the company may have to approve the transfer even after a ROFR is waived or declined. Co-sale / tag-along can let other holders sell alongside the seller on a proportional basis.

None of those clauses live in your SPV operating agreement. They live in the underlying equity documents. The SPV subscription package cannot waive them. See how to set up a secondary SPV for the formation sequence once the transfer path is real.

Market color on why secondary volume rose sits in venture secondaries in 2026. This post is the ROFR underwriting problem, not a volume thesis.

ROFR secondary SPV: underwrite before you raise

GPs lose weeks when they market a Premium SPV, collect soft circles, then discover the company will exercise ROFR or refuse consent. Run the document read first.

1. Get the seller’s equity documents. Cap table excerpt, SPA or option exercise paperwork, IRA / stockholders’ agreement, bylaws transfer article, any side letter on liquidity.

2. Identify who holds the ROFR / ROFO / consent. Company only, preferred holders, or both. Note notice method, response window, and whether “same terms” includes structure (cash vs deferred, escrow, indemnities).

3. Ask whether the buyer entity is acceptable. Many companies will not approve a multi-member SPV, a series cell, or an unknown syndicate vehicle without KYC on the manager and beneficial owners.

4. Separate price agreement from transfer clearance. A signed secondary SPA with a “subject to ROFR and consent” condition is normal. Treating that condition as a formality is not.

5. Decide whether the SPV closes before or after clearance. Closing LP subscriptions into cash while the transfer is still contingent creates broken-deal and escrow design work. Align the closing checklist with counsel’s transfer timeline.

Published Allocations formation prices (fetched 4 Sep 2026): Standard SPV $9,950 one-time; Premium SPV $19,500 one-time (secondaries as an asset type typically use Premium); Fund $19,500/year; platform carry 0%. Extra investors +$100; extra Premium closes $2,000. Additional fees may apply. See fees and SPVs.

How ROFR interacts with the SPV stack

Disclosure. The PPM or deal memo should state that the underlying transfer is contingent on ROFR, consent, and related restrictions, and that the SPV may never acquire the shares. That is disclosure, not a contract with the company. PPM vs subscription vs operating agreement is the document stack; keep the contingency language consistent across all three.

Subscription. LPs subscribe to SPV interests. Their money funds the secondary purchase if the transfer clears. Escrow, delayed closing, or a condition precedent to admitting capital should be drafted, not improvised in Slack.

Operating agreement. Manager authority to abandon the deal, return capital, or pivot to a different block (if any) belongs in the OA. Do not imply a put to an ATS or a guaranteed company buyback.

Broker-dealer vs admin. If the block is sourced or matched through a broker-dealer process, keep brokerage separate from vehicle admin. AllocationsX (FINRA/SIPC, CRD 317750) is not a substitute for reading the company’s ROFR. Nothing here is an offer of any security on any ATS.

What “same terms” fights look like

ROFR disputes often land on whether the third-party deal’s structure is matchable. Cash at closing is easy to match. Deferred purchase price, earnouts, repurchase rights, or indemnities that only the strategic buyer would give are harder. Company counsel may argue the ROFR package must be stripped to pure cash; buyer counsel may argue the preferred party must match the whole package. That is a facts-and-documents fight. Do not invent a market “standard” percentage or day count in LP materials — use the actual contract windows.

If the company exercises, your SPV may receive returned capital (net of agreed expenses) instead of stock. Tell LPs that outcome is possible before first wire. If the company waives and consents, close the transfer, update the SPV’s books, and run post-close admin through the ordinary path on banking (dedicated vehicle account) and K-1 support.

Common GP mistakes

• Marketing the secondary as “locked” before ROFR notice went out.

• Forming the SPV in a structure the company’s transfer policy has already rejected (anonymous multi-member vehicles, series cells without prior approval).

• Ignoring co-sale rights that shrink the block the SPV can buy.

• Mixing primary-round SPA language into a secondary transfer memo.

• Quoting ATS liquidity as a backstop if ROFR kills the deal. Liquidity is not guaranteed; matching is not guaranteed; this page is not an offer.

When counsel should slow you down

Slow down when the seller cannot produce the IRA, when preferred holders share the ROFR, when the buyer must be a single accredited individual rather than an SPV, or when the shares are still subject to a company repurchase right. Those are deal-killers or redesigns, not admin tickets.

A ROFR secondary SPV is underwritable. It is not “just like a primary” with a different SPA cover page. Read the transfer article, run the notice, get consent in writing, then close the vehicle.

Does a company ROFR always kill a secondary SPV?

No. Many ROFRs are waived or expire unused. The risk is process and timing: notice, response windows, and consent can delay or resize the block. Underwrite before you raise, and disclose the contingency to LPs.

Is ROFR the same as company consent?

No. ROFR is a matching right on sale terms. Consent is a separate approval to transfer. You can clear one and still fail the other. Read both clauses.

Can Allocations waive a portfolio company’s ROFR?

No. ROFR and consent sit in the company’s equity documents. Allocations administers the SPV; it does not control the issuer’s transfer restrictions. Premium SPV pricing for secondaries as an asset type is on fees — that is formation/admin, not a ROFR waiver.

What if the ROFR is exercised after LPs have wired?

That depends on how the subscription, escrow, and SPA conditions were drafted. Typical designs return capital (net of agreed expenses) if the transfer fails. Do not assume a default without reading your documents. Counsel owns that call.

Does mentioning AllocationsX mean this is an offer?

No. This page is not an offer or solicitation to buy or sell any security. Allocations Securities, LLC dba AllocationsX (FINRA/SIPC, CRD 317750) is identified only so GPs do not confuse broker-dealer secondaries with SPV administration.